Session I: Current Management of NASH

This initial session is intended to set the foundation for the meeting by providing an overview of our current understanding of NAFLD/NASH as it pertains to epidemiology, natural history, pathogenesis, liver biopsy diagnosis and current treatment. This session will help frame the current challenges we are facing with NASH and drug development in this field.

SPEAKERS

Program Chairs:
Rohit Loomba, MD
Stephen A. Harrison, MD, FAASLD

Moderators:
Raymond T. Chung, MD, FAASLD
Suzanne R. Sharpton, MD, MAS

Presenters:
Zobair M. Younossi, MD, MPH, FAASLD - Epidemiology and Natural History of NASH
Brent A. Tetri, MD, FAASLD - Pathogenesis of NASH
David Kleiner, MD, PhD - Liver Histologic Assessment and Differential Diagnosis in NAFLD
Kathleen E. Corey, MD, MPH, MMSc - Lifestyle, Current Pharamacologic Treatment of NASH and Bariatric Surgery